Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
78 participants
INTERVENTIONAL
2011-06-30
2013-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Benefits of FloraGLO™ Lutein on Skin Health
NCT03769779
Efficacy of Solarplast for Health and Oxidative Stress
NCT04144777
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Sunscreen Products
NCT05085327
The Effect of Dates on Plasma Lipids, Oxidative Stress and the Atherogenicity of Serum in Healthy Adults
NCT00750789
Inflammation, Polyphenols, and Genetics
NCT01568827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dark chocolate
Flavanol-rich chocolate
Flavanol-rich chocolate
High-flavanol chocolate, 12 weeks.
Placebo chocolate
Flavanol-free chocolate
Flavanol-free chocolate
Flavanol-free chocolate, 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flavanol-rich chocolate
High-flavanol chocolate, 12 weeks.
Flavanol-free chocolate
Flavanol-free chocolate, 12 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal skin of type I and II as decried by Fitzpatrick classification.
Exclusion Criteria
* Photo sensibility: history of skin cancers, photosensitizing medication.
* Sun bed use or sunbathing in the previous 3 months.
* Use of supplements or natural health products (fish oils, coenzyme Q10, garlic, lycopene, beta carotene).
* Allergy or intolerance to nuts or chocolate.
20 Years
65 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudine Blanchet
Coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvie Dodin, MD
Role: PRINCIPAL_INVESTIGATOR
Laval University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laval university, Department of Medicine, Institut des nutraceutiques et des aliments fonctionnels.
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mogollon JA, Boivin C, Lemieux S, Blanchet C, Claveau J, Dodin S. Chocolate flavanols and skin photoprotection: a parallel, double-blind, randomized clinical trial. Nutr J. 2014 Jun 27;13:66. doi: 10.1186/1475-2891-13-66.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Callebaut-10151
Identifier Type: OTHER
Identifier Source: secondary_id
Callebaut-10151
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.